In this Issue:
Primary chemotherapy vs primary surgery for advanced ovarian cancer
Ovarian cancer screening using risk algorithm and serial biomarker measurements
Cancer risk in women with newly diagnosed endometriosis or adenomyosis
Epirubicin, cisplatin, & capecitabine for primary platinum-resistant/refractory epithelial ovarian cancer
Exercise intervention for women with recurrent ovarian cancer
Effectiveness of risk algorithms in women with ovarian cancer
Fertility sparing surgery vs standard radical surgery in early stage ovarian cancer
Veliparib in ovarian cancer patients carrying a germline BRCA1 or BRCA2 mutation
Delay in chemotherapy and survival in elderly patients with epithelial ovarian cancer
Predictors of postoperative morbidity after cytoreduction for advanced ovarian cancer
Please login below to download this issue (PDF)